<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04583163</url>
  </required_header>
  <id_info>
    <org_study_id>2019-0945</org_study_id>
    <nct_id>NCT04583163</nct_id>
  </id_info>
  <brief_title>Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients</brief_title>
  <official_title>Inter- and Intra-Observer Variability in Transcranial Doppler (TCD) Technique in Neurocritical Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hackensack Meridian Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hackensack Meridian Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine the inter- and intra-variability of Transcranial Doppler (TCD)&#xD;
      ultrasound in neuro-critical care patients who are planned for consecutive daily TCD&#xD;
      evaluations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients enrolled in the study are recruited from the pool of neuro-critical care patients&#xD;
      admitted to the surgical intensive care unit (SICU). When the patients are admitted in the&#xD;
      surgical ICU, the study staff will determine eligibility based on the protocol inclusion&#xD;
      criteria. Due to the nature of the disease, there is a high likelihood that patients are&#xD;
      either unconscious, of limited mental capacity and/or have been intubated therefore when&#xD;
      appropriate the legally authorized representative will be utilized to obtain research&#xD;
      consent.&#xD;
&#xD;
      To meet study inclusion, transcranial Doppler (TCD) testing will be ordered as part of the&#xD;
      standard of care for these patients. The test will not be ordered solely for research&#xD;
      purposes. There are no known side effects from the non-invasive measurement of cerebral blood&#xD;
      flow using ultrasound&#xD;
&#xD;
      Three different TCD technicians will do triplicate readings on 3 consecutive days on up to 12&#xD;
      patients already undergoing TCD as ordered by their treating team. Standard of care on&#xD;
      specific neuro critical care patients (such as cerebral aneurysms) is to undergo daily TCD&#xD;
      monitoring to assess for possible vasospasm. Patients will be in the supine position while&#xD;
      measurements are obtained. The probe will be placed in the preauricular region of the&#xD;
      temporal window&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the inter- and intra-variability of TCD ultrasound in neuro-critical care patients</measure>
    <time_frame>Three different TCD technicians will do triplicate readings on 3 consecutive days on patients already undergoing TCD as ordered by their treating team</time_frame>
    <description>This study aims to determine the inter- and intra-variability of Transcranial Doppler (TCD) ultrasound in 12 neuro- critical care patients who are planned for daily TCD evaluation. Up to 12 subjects will be recruited over a 1 year period. Patients enrolled in the study are recruited from the pool of neuro-critical care patients admitted to the surgical intensive care unit (SICU). The study aims to determine the inter- and intra-variability of TCD ultrasound in neuro critical care patients who are planned for daily TCD evaluation. The following measurements will be assessed:&#xD;
The peak and mean flow velocity of the middle cerebral artery (MCA)&#xD;
The peak and mean flow velocity of the posterior cerebral artery (PCA)&#xD;
The peak and mean flow velocity of the basilar arteries</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describe the change in velocity that prompts clinical intervention in symptomatic and asymptomatic vasospasm in neuro-critical care patients</measure>
    <time_frame>Data will be assessed from TCD readings performed on triplicate readings on 3 consecutive days on patients already undergoing TCD as ordered by their treating team</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Cerebral Aneurysm</condition>
  <condition>Stroke</condition>
  <condition>Vasospasm, Cerebral</condition>
  <condition>Subarachnoid Hemorrhage, Aneurysmal</condition>
  <condition>Aneurysmal Subarachnoid Hemorrhage</condition>
  <condition>Cerebral Ischemia</condition>
  <arm_group>
    <arm_group_label>Neuro-critical Care Patients</arm_group_label>
    <description>Up to 12 subjects will be recruited over a 1 year period. Patients enrolled in the study are recruited from the pool of neuro-critical care patients admitted to the surgical intensive care unit (SICU).&#xD;
To meet study inclusion, transcranial Doppler (TCD) testing will be ordered as part of the standard of care for these patients. The test will not be ordered solely for research purposes. There are no known side effects from the non-invasive measurement of cerebral blood flow using ultrasound.&#xD;
Three different TCD technicians will perform triplicate readings on 3 consecutive days on up to 12 patients already undergoing TCD as ordered by their treating team. Standard of care on specific neuro critical care patients (such as cerebral aneurysms) is to undergo daily TCD monitoring to assess for possible vasospasm. Patients will be in the supine position while measurements are obtained. The probe will be placed in the preauricular region of the temporal window.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Transcranial Doppler</intervention_name>
    <description>Transcranial Doppler is a non-invasive, painless, ultrasound technique that uses high frequency sound waves to measure the rate and direction of blood flow vessels in the brain.</description>
    <arm_group_label>Neuro-critical Care Patients</arm_group_label>
    <other_name>TCD</other_name>
    <other_name>TCD Ultrasound</other_name>
    <other_name>Transcranial Doppler Ultrasound</other_name>
    <other_name>Transcranial Neurovascular Exam</other_name>
    <other_name>TCD Study</other_name>
    <other_name>Transcranial Doppler Study</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neuro-critical care patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults 18 years of age or older&#xD;
&#xD;
          2. Current hospitalization for a neurologic issue and admitted to the surgical intensive&#xD;
             care unit.&#xD;
&#xD;
          3. Undergoing daily transcranial Doppler imaging No&#xD;
&#xD;
          4. English speaking patients and/or legally authorized representative (LAR)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Less than 18 years of age&#xD;
&#xD;
          2. Patient is unable to obtain consent and no LAR is identified to provide consent&#xD;
&#xD;
          3. Non-English speaking patient or LAR&#xD;
&#xD;
          4. Unable to perform the study due to lack of availability of TCD technologists&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Stephen M Cohn, MD FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hackensack Meridian Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa Blatt, MSN</last_name>
    <phone>551-996-2000</phone>
    <email>Melissa.Blatt@hmhn.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tania Zielonka, CCRP</last_name>
    <phone>551-996-2000</phone>
    <phone_ext>4452</phone_ext>
    <email>tania.zielonka@hmhn.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Blatt, MSN</last_name>
      <phone>551-996-2000</phone>
      <email>melissa.blatt@hmhn.org</email>
    </contact>
    <contact_backup>
      <last_name>Tania Zielonka, CCRP</last_name>
      <phone>551-996-2000</phone>
      <phone_ext>4452</phone_ext>
      <email>tania.zielonka@hmhn.org</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen M Cohn, MD FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jyoti Sharma, MD FACS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.</citation>
    <PMID>2868172</PMID>
  </reference>
  <results_reference>
    <citation>Oyama K, Criddle L. Vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Nurse. 2004 Oct;24(5):58-60, 62, 64-7. Review.</citation>
    <PMID>15526491</PMID>
  </results_reference>
  <results_reference>
    <citation>Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016 May;124(5):1257-64. doi: 10.3171/2015.4.JNS15428. Epub 2015 Oct 23. Review.</citation>
    <PMID>26495942</PMID>
  </results_reference>
  <results_reference>
    <citation>Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016 Oct 14;20(1):277. Review.</citation>
    <PMID>27737684</PMID>
  </results_reference>
  <results_reference>
    <citation>Carrera E, Schmidt JM, Oddo M, Fernandez L, Claassen J, Seder D, Lee K, Badjatia N, Connolly ES Jr, Mayer SA. Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery. 2009 Aug;65(2):316-23; discussion 323-4. doi: 10.1227/01.NEU.0000349209.69973.88.</citation>
    <PMID>19625911</PMID>
  </results_reference>
  <results_reference>
    <citation>Rigamonti A, Ackery A, Baker AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anaesth. 2008 Feb;55(2):112-23. doi: 10.1007/BF03016323. Review.</citation>
    <PMID>18245071</PMID>
  </results_reference>
  <results_reference>
    <citation>Maeda H, Etani H, Handa N, Tagaya M, Oku N, Kim BH, Naka M, Kinoshita N, Nukada T, Fukunaga R, et al. A validation study on the reproducibility of transcranial Doppler velocimetry. Ultrasound Med Biol. 1990;16(1):9-14.</citation>
    <PMID>2181766</PMID>
  </results_reference>
  <results_reference>
    <citation>Baumgartner RW, Mathis J, Sturzenegger M, Mattle HP. A validation study on the intraobserver reproducibility of transcranial color-coded duplex sonography velocity measurements. Ultrasound Med Biol. 1994;20(3):233-7.</citation>
    <PMID>7914715</PMID>
  </results_reference>
  <results_reference>
    <citation>Totaro R, Marini C, Cannarsa C, Prencipe M. Reproducibility of transcranial Dopplersonography: a validation study. Ultrasound Med Biol. 1992;18(2):173-7.</citation>
    <PMID>1580013</PMID>
  </results_reference>
  <results_reference>
    <citation>Shen Q, Stuart J, Venkatesh B, Wallace J, Lipman J. Inter observer variability of the transcranial Doppler ultrasound technique: impact of lack of practice on the accuracy of measurement. J Clin Monit Comput. 1999 May;15(3-4):179-84.</citation>
    <PMID>12568169</PMID>
  </results_reference>
  <results_reference>
    <citation>Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979 Mar;86(2):420-8. Review.</citation>
    <PMID>18839484</PMID>
  </results_reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2020</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transcranial Doppler</keyword>
  <keyword>TCD</keyword>
  <keyword>Interrater Variability</keyword>
  <keyword>Intrarater Variability</keyword>
  <keyword>Transcranial Doppler Ultrasound</keyword>
  <keyword>Neurocritical Care</keyword>
  <keyword>DCI</keyword>
  <keyword>Delayed Cerebral Ischemia</keyword>
  <keyword>MCA</keyword>
  <keyword>PCA</keyword>
  <keyword>Mean Flow Velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

